214 related articles for article (PubMed ID: 25866158)
21. [Bifunctional Toxin DARP-LoPE Based on the HER2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics].
Proshkina GM; Kiseleva DV; Shilova ON; Ryabova AV; Shramova EI; Stremovskiy OA; Deyev SM
Mol Biol (Mosk); 2017; 51(6):997-1007. PubMed ID: 29271963
[TBL] [Abstract][Full Text] [Related]
22. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
Yates SP; Merrill AR
Biochem J; 2004 May; 379(Pt 3):563-72. PubMed ID: 14733615
[TBL] [Abstract][Full Text] [Related]
23. [Immunobiological properties of recombinant atoxic forms of the Pseudomonas aeruginosa exotoxin A].
Isakov MA; Soldatenkova AS; Kaloshin AA; Mikhaĭlova NA
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):37-42. PubMed ID: 21598613
[TBL] [Abstract][Full Text] [Related]
24. [Construction, expression and functional characterization of disulfide-stabilized anti-hepatocarcinoma single chain Fv fused with truncated Pseudomonas exotoxin].
Zhao J; Sun ZW; Liu YF; Yu WY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):585-7. PubMed ID: 15182657
[TBL] [Abstract][Full Text] [Related]
25. Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.
Gawlak SL; Pastan I; Siegall CB
Bioconjug Chem; 1993; 4(6):483-9. PubMed ID: 7508267
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin.
Ogata M; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4215-9. PubMed ID: 2657746
[TBL] [Abstract][Full Text] [Related]
27. [Target-specific cytotoxic activity of recombinant fusion toxin C-CPE-ETA' against CLDN-3,4-overexpressing ovarian cancer cells].
Yao Q; Zheng QM; Wen JF; Lü T; Wei MQ; Dai SZ
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):897-902. PubMed ID: 21223796
[TBL] [Abstract][Full Text] [Related]
28. Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.
Santajit S; Seesuay W; Mahasongkram K; Sookrung N; Ampawong S; Reamtong O; Diraphat P; Chaicumpa W; Indrawattana N
Sci Rep; 2019 Oct; 9(1):14928. PubMed ID: 31624289
[TBL] [Abstract][Full Text] [Related]
29. Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A.
Wang H; Dai J; Li B; Fan K; Peng L; Zhang D; Cao Z; Qian W; Wang H; Zhao J; Guo Y
Protein Expr Purif; 2008 Mar; 58(1):140-7. PubMed ID: 17950620
[TBL] [Abstract][Full Text] [Related]
30. Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes.
Onda M; Beers R; Xiang L; Lee B; Weldon JE; Kreitman RJ; Pastan I
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5742-7. PubMed ID: 21436054
[TBL] [Abstract][Full Text] [Related]
31. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.
Joshi BH; Puri RK
Protein Expr Purif; 2005 Feb; 39(2):189-98. PubMed ID: 15642470
[TBL] [Abstract][Full Text] [Related]
32. [Construction and expression of the gene CD4V1V2-PE40, coding for a molecular targeted protein against AIDS].
Zhao X; Zhang M; Li H; Lu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Aug; 17(4):248-52. PubMed ID: 8575044
[TBL] [Abstract][Full Text] [Related]
33. Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancers.
Yao Q; Cao S; Li C; Mengesha A; Low P; Kong B; Dai S; Wei M
Biochem Biophys Res Commun; 2010 Jul; 398(3):413-9. PubMed ID: 20599713
[TBL] [Abstract][Full Text] [Related]
34. A re-evaluation of the role of histidine-426 within Pseudomonas aeruginosa exotoxin A.
Roberts TM; Merrill AR
Biochem J; 2002 Nov; 367(Pt 3):601-8. PubMed ID: 12160465
[TBL] [Abstract][Full Text] [Related]
35. Regulation of toxA by PtxR in Pseudomonas aeruginosa PA103.
Carty NL; Rumbaugh KP; Hamood AN
Can J Microbiol; 2003 Jul; 49(7):450-64. PubMed ID: 14569286
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9738-42. PubMed ID: 3264406
[TBL] [Abstract][Full Text] [Related]
37. A dominant-negative approach that prevents diphthamide formation confers resistance to Pseudomonas exotoxin A and diphtheria toxin.
Roy V; Ghani K; Caruso M
PLoS One; 2010 Dec; 5(12):e15753. PubMed ID: 21203470
[TBL] [Abstract][Full Text] [Related]
38. Characterization of single-chain antibody (sFv)-toxin fusion proteins produced in vitro in rabbit reticulocyte lysate.
Nicholls PJ; Johnson VG; Andrew SM; Hoogenboom HR; Raus JC; Youle RJ
J Biol Chem; 1993 Mar; 268(7):5302-8. PubMed ID: 8444903
[TBL] [Abstract][Full Text] [Related]
39. Potent and specific fusion toxins consisting of a HER2‑binding, ABD‑derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A.
Liu H; Lindbo S; Ding H; Altai M; Garousi J; Orlova A; Tolmachev V; Hober S; Gräslund T
Int J Oncol; 2019 Jul; 55(1):309-319. PubMed ID: 31180549
[TBL] [Abstract][Full Text] [Related]
40. Immunotoxin-mediated targeting of claudin-4 inhibits the proliferation of cancer cells.
Hashimi SM; Yu S; Alqurashi N; Ipe DS; Wei MQ
Int J Oncol; 2013 Jun; 42(6):1911-8. PubMed ID: 23563899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
